IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Performance
Performance Report
Fabino Life Sciences IPO listing price is ₹ 40.35, issue price is ₹ 36.00, and currently trading at ₹ 25.00 as on May 20, 2025. Fabino Life Sciences IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Fabino Life Sciences IPO is a Fixed Price listing on BSE SME exchange. The company is based in New Delhi and caters to Pharmaceutical sector. Aryaman Financial Services is the merchant banker of Fabino Life Sciences IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 26th November 2021.
Fabino Life Sciences IPO offer price is ₹ 36.00 and got listed at ₹ 40.35. Read Fabino Life Sciences IPO details mentioned above.The IPO of Fabino Life Sciences Limited was listed on 13th January 2022. As of today, Fabino Life Sciences IPO is trading at ₹ 25.00, compared to the previous day’s close of ₹ 25.95. Read the report above for detailed IPO performance.
The issue price of Fabino Life Sciences IPO was ₹ 36.00 per equity share.
Fabino Life Sciences IPO was listed at ₹40.35 on the stock exchange on 13th January 2022. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of May 20, 2025, the current market price of Fabino Life Sciences IPO is ₹ 25.00.
The 52-week high for Fabino Life Sciences IPO is [●], while the 52-week low is [●]. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Fabino Life Sciences IPO listed at ₹ 40.35 against the issue price of ₹ 36.00 per equity share, showing a listing day gain/loss of 4.35 (12.08%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Fabino Life Sciences IPO stock moved from its listing price of ₹ 40.35 to the current price of ₹25.00 per equity share, reflecting a change of -38.04% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Fabino Life Sciences IPO issue date of May 20, 2025 and CMP of ₹25.00, the estimated CAGR is approximately -10.3%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Face
Value :
₹ 10
Issue
Price :
₹ 36.00
Listing Price :
₹ 40.35
Previous Day Closing
₹ 25.95
Fabino Life Sciences IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Fabino Life Sciences Financial Review Page
Merchant Banker(s) of Fabino Life Sciences IPO: Aryaman Financial Services Limited
Fabino Life Sciences IPO subscription was 6.93 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Fabino Life Sciences IPO listed at a listing price of 40.35 against the offer price of 36.00.
The current market price of Fabino Life Sciences is 25.00.
Why Us?
